RBB

Dean Curry

Dean is a Principal based in RBB’s Madrid office with over ten years’ experience. He has advised clients on numerous high-profile merger and abuse of dominance cases before the European Commission and CMA, particularly in tender markets and the pharmaceutical sector.

Dean has over ten years of experience advising clients across a wide range of cases before the European Commission, the CMA, other national competition authorities, and multiple courts.

His experience spans a range of competition matters. He has advised on a number of high-profile mergers, alleged abuse of a dominant position cases, and litigation matters in court.

He has advised numerous high-profile clients such as Teva, Siemens, Pfizer, Lloyds Banking Group, General Electric, Henkel, Alstom, McCain Foods, Sony, Generics UK, and Santander.

Dean has in-depth experience in the assessment of tender markets and pharmaceutical industry from advising on many high-profile cases in these areas. However, he also has experience in many other sectors such as retail, rolling stock, financial services, debt collection, tobacco farming, rail electrification, insurance, and banking.

He holds a Master’s degree in Economics from the Barcelona School of Economics, and a first class honours undergraduate degree in Economics.

Selected Cases

  • Siemens/Alstom

    Merger, Global

  • Teva/Allergan

    Merger, EU

  • Teva (Copaxone)

    Alleged abuse of dominance, EU

  • Teva (Copaxone)

    Damages litigation, Germany

  • Generics UK (Paroxetine)

    Alleged abuse of dominance, UK (CAT)

  • Sony/ATV/Sony Music

    Merger, EU

  • Metso/Outosec

    Merger, EU

  • Nordic Capital/Intrum Justitia

    Merger, EU

  • General Electric/Avio

    Merger, EU

  • Lloyd's Banking Group/Standard Life

    Litigation, UK

A global network of experienced experts

Our 230-strong, multi-lingual team, spread across 16 offices, has managed over 3,000 cases in 120+ countries, advising on more than one-third of EU Phase II cases in the last 5 years.